About renublatestreport

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Global Dialysis Market Size registered a CAGR of 5.7% from 2021 to 2027

As per the latest report by Renub Research titled “Global Dialysis Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” Global Dialysis Market Size was USD 92.5 Billion in 2021. Worldwide, dialysis is an essential and life-saving treatment for chronic renal failure (CRF), kidney diseases, end-stage renal disease (ESRD). Dialysis is a treatment that purifies blood using a machine. It utilizes special equipment to remove excess water and waste products from the blood. In this procedure, the blood is filtered, excess toxins and fluid are removed, and electrolyte balance is restored. Dialysis is carried out in two ways: peritoneal and hemodialysis dialysis. Both perform the usual filtering of waste kidney functions and excess fluid from the blood.

Key Factors Driving the Growth of the Dialysis Industry:

Dialysis market growth is driven by the increasing diabetic population, higher prevalence among ageing population, and rising cases of ESRD are anticipated to drive the market. Further, an increase in the advancement of home-based services and the number of treatment centers are the aspects attributing toward the dominance of the services segment. Moreover, improved reimbursement policies for renal treatment by private and public institutions are encouraging the expansion of the market at a remarkable rate. For instance, in 2020, according to the End-Stage Renal Disease (ESRD) PPS final rule, the Centers for Medicare & Medicaid Services (CMS) to pay around US$ 10.3 billion in Medicare reimbursements to about 7,000 ESRD providers for the costs of delivering renal hemodialysis services.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-dialysis-market-p.php

How Coronavirus Affected the Dialysis Industry

Besides, the COVID-19 pandemic had a moderate impact on the market. COVID-19 is majorly a respiratory disease, but it has also been shown to impact kidneys, damaging the organ to cause acute renal infection (AKI). The pandemic also disrupted the supply chain operations and affected the availability of hemodialysis, consumables for peritoneal dialysis, and essential medicines, leading to a drop in dialysis procedures performed in several dialysis centers. Due to such adverse scenarios, the overall impact of the COVID-19 pandemic on the market is to be substantial.

Hemodialysis to Account for Maximum Share

Based on type, the dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is a significant contributor to the dialysis market growth. Hemodialysis helps balance minerals such as sodium, calcium, and potassium that aids in decreasing blood pressure. Routine hemodialysis is conducted in a hospital, dialysis outpatient facility, or a dedicated stand-alone clinic that surges the market demand. Also, the growing prevalence of chronic kidney diseases across the globe will boost the acceptance rate of hemodialysis among the patient population base. Hemodialysis is classified into short daily, conventional hemodialysis, hemodialysis, and nocturnal hemodialysis.

In terms of end-users, the dialysis market is segmented into in-center and home dialysis. Dialysis treatments centers accounted for the significant market, attributable to the favorable reimbursement provided by renal facilities. Most patients prefer to obtain dialysis treatments through services delivered by dialysis centers making them the most significant contributor to the global dialysis market. Regardless, a rise in awareness and surge in demand for home healthcare among dialysis patients is predicted to make home dialysis the fastest-growing segment during the forecast period. Home dialysis offers several benefits, including reducing travel expenses, improved quality of life, flexibility, and accessible patient mobility.

Rising Dialysis Cases in the North American Region will Fuel the Industry’s Progression:

Amongst regions worldwide, North America is projected to lead the dialysis market owing to the higher usage of dialysis therapy to treat several end-stage renal diseases and chronic kidney diseases. The high prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the pivotal factors estimated to boost the expansion of the market during the forecast period. Further, the North American region is projected to see growth attributable to the growing incidence of coronavirus infections and succeeding renal failures. Likewise, the Asia-Pacific region is anticipated to witness the growth in dialysis market during the coming year, which is attributed to a low rate of organ transplantation, surge in the incidence rate of kidney failure, and advancement in healthcare expenditure.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-dialysis-market-p.php

Competitive Landscape

The prominent players operating in the dialysis market include Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc. These variant market participants are undertaking various progressive strategies to capture a higher revenue share in this dialysis market. Several development strategies enforced by foremost market players have helped them maintain a strong position in the industry.

Market Summary:

  • Type – We have covered Global Dialysis Market breakup by 2 viewpoints by Type (Hemodialysis, Peritoneal dialysis)
  • Product & Services – Renub Research Report covers by Product & Services in the 4 viewpoints (Services, Equipment, Consumables, and Drugs)
  • End-Users – Our Report has covered Global Dialysis Market breakup by end-users 2 viewpoints (In-center dialysis, Home dialysis)
  • Regions – Global Dialysis Market has covered by Region 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Advertisement

Worldwide Bioplastics Industry will expand with a CAGR of 6.7% during 2021-2027

As per the latest report by Renub Research titled “Bioplastic Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Bioplastic Market Size was USD 6.7 Billion in 2021. Bioplastic is recognized as a very positive and essential innovation in the plastics and chemicals industry. Bioplastic is materials emanated from renewable sources that can reduce plastic waste generation on the planet. It can reduce 30-70% of carbon dioxide emissions. It represents an approximately 42% reduction of carbon footprints. The production of bioplastic requires 65% less energy than conventional petroleum plastic. These bio-based plastics are generally sourced from renewable biomass sources, including vegetable fats, natural sugars, cellulose, plant starch, and waste oils.

Global Bioplastics Market to Reach USD 9.9 Billion by 2027

Over the short term, significant factors driving the market studied are environmental factors promoting a paradigm shift and increasing demand for bioplastics in flexible packaging. The ecological dilemma caused by reaching high levels of greenhouse gas emissions in the atmosphere is one of the main drivers for the bioplastic industry, as bioplastic help to reduce the dependency on fossil resources, reduce greenhouse gas (GHG) emissions, and increase resource efficiency.

COVID-19 Impact on Bioplastics Growth Trends

The bioplastic market was positively impacted by COVID-19. Amid the lockdown situation, the demand for flexible packaging has increased, owing to the rise in demand for food, pharma, and PPE packaging personal and healthcare products. However, sustainable plastics can be an excellent alternative to conventional plastics, thus delivering an alternative growth pathway to the bioplastic industry in the wake of the COVID -19 pandemic.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=bioplastics-market-p.php

Non-biodegradable Plastics Polyethylene Terephthalate (PET) Segment led the Market

Non-biodegradable bioplastic are further categorized into Polyethylene (P.E.), Polyethylene terephthalate (PET), Polyamide (P.A.), Polypropylene (P.P.), Poly(trimethylene terephthalate) (PTT) and Others. Polyethylene terephthalate is an ideal choice for use in various industries such as automotive, electronics, and textiles due to its features. Polyethylene terephthalate, commonly known as PET, is a lightweight, non-toxic, safe, and flexible material that can be reused and recycled efficiently. It can also be processed 3 to 4 times without impacting its chemical properties. Meanwhile, polyethylene terephthalate offers unique physical properties, such as it is shatterproof and non-reactive to food and water, so it is widely utilized in flexible packaging applications. The growing technological advances and innovations in packaging applications, mainly through weight reduction, will positively influence market growth.

Packaging Application is anticipated to Exhibit Rapid Growth

The adoption of bioplastic has increased tremendously across various applications like packaging, agriculture, consumer goods, textile, automotive and transportation, and building and construction, owing to the advanced technical properties and functionalities. Bio-based plastics have found traction in packaging applications due to shipping companies seeking sustainable sturdy packaging products. The packaging segment is further divided into jars, trays, bottles & and others, while flexible packaging is further categorized into shopping/waste, pouches, bags, etc. Moreover, most packaging products are nowadays produced from traditional plastics and end up in landfills, which is a situation that various governments intend to address.

Regionally, North America accounted for the Largest Bioplastics Market

North America’s bioplastics market is majorly caused by the growing demand from the packaging industry in countries like Canada, U.S., and Mexico. Rising environmental concerns and a global attempt to decrease pollution are propelling the demand for biodegradable plastics in the packaging sector across the region. In addition, increasing COVID-19 cases in the U.S. results in a raised demand for generic drugs and medical devices, this boosts the demand for bioplastics in the medical packaging sector, positively impacting the market growth.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/bioplastics-market-p.php

Similarly, Asia Pacific is likely to have a considerable market due to the availability of skilled labor at a low cost. Further, easy land availability for manufacturing industries drives the regional market. The transformation in the production landscape of biodegradable plastics toward emerging economies, particularly China and India, is to influence bioplastics market growth positively. The bioplastics market is fragmented into key players like Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (U.K.), Green Dot Bioplastics.

Market Summary:

Material Type – We have covered Bioplastics Market breakup by 2 viewpoints by- Material Type (Biodegradable (Polybutylene adipate Terephthalate (PBAT),Polybutylene Succinate (PBS),Polylactic Acid (PLA),Polyhydroxyalkanoate (PHA),Starch Blends and Others), Non Biodegradable (Polyethylene (PE),Polyethylene terephthalate (PET),Polyamide (PA), Polypropylene (PP,Polytrimethylene terephthalate) ( PTT) and Others))

Application – Renub Research Report covers by application in the 6 viewpoints (Packaging, Agriculture, Consumer Goods, Textile, Automotive and Transportation, And Building and Construction)

Region – Our Report has covered Bioplastics Market breakup by 4 Region (North America, Europe, Asia Pacific and Rest of the Word)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (U.K.), Green Dot Bioplastics.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Spinal Fusion Market to Reach USD 9.93 Billion by 2027

According to Renub Research, report titled “Spinal Fusion Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis” the Global Spinal Fusion Device Market was USD 7.48 Billion in 2021. Surgical procedures and implant-device (cage) technologies for spinal fusion have evolved dramatically over 40 years. Furthermore, design and materials have developed with a single purpose in mind: to create implants that satisfy all three critical concerns of the procedure: stability, lordosis restoration, and osteointegration. As a result, spinal fusion remains the gold standard for treating spinal instability, deformity, and degenerative illness. Spinal fusion, also known as spinal arthrodesis, is a surgical operation that involves joining two or more vertebral bodies in the spine.

Worldwide Spinal Fusion Device Market is anticipated to grow at a CAGR of 4.8% from 2021-2027

The global spinal fusion devices market is predicted to increase moderately, opening up a slew of new prospects. The increase in the elderly population and the rise in the frequency of spinal illnesses are driving the market’s expansion. In addition, the market is expected to rise as the number of indications for spinal fusion surgery grows. For example, spinal fusion was once reserved for scoliosis and spinal tuberculosis, but it is now used to treat 14 other disorders. It’s also worth noting that technological advancements are helping to drive the business forward.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=global-spinal-fusion-market-procedure-volume-and-forecast-495-p.php

The Thoracolumbar Devices Segment Is the Market Leader:

By product type, Cervical Device, Thoracolumbar Device, Interbody Device, and Biologics are covered in our report. According to our research, the thoracolumbar devices category dominates the spinal fusion device market. The segment is being driven even further by the rising incidence of spinal problems such as spinal stenosis, severe kyphosis, and vertebral fracture. In most of these cases, surgery is the only choice for treatment. Furthermore, thoracolumbar fractures can be the most common reason for surgical intervention. Road accidents or bone insufficiency are the two most common causes of fractures. Bone insufficiency is caused by underlying conditions such as osteoporosis and tumors, weakening the bone and leading to fractures.

The Degenerative Disc Segment Is Rapidly Growing:

In our report, we have studied Degenerative Disc Disease, Complex Deformity, and Traumas & Fractures as disease indicator types. Over the projection period, the complex deformity segment would dominate the market for spinal fusion devices. On the other hand, expanding reasons for lower back and neck discomfort in adults and an increase in the older population are the main factors driving the degenerative disc segment. In addition, the evolution of sports and daily activities is predicted to contribute to category expansion. As a result, according to our analysis, the degenerative disc section of the spinal fusion market is expected to multiply.

End-user Perspectives on the Spinal Fusion Device Industry:

Our report covers Ambulatory Surgical, Specialty Clinics, and Hospitals. For decades, one of the elements propelling the hospital segment has been the increasing number of spine procedures conducted in hospitals. Furthermore, in developing countries such as India, significant government measures to enhance healthcare infrastructure and develop the middle-class population result in augmented demand for excellent healthcare services offered by hospitals, assisting segment expansion. As a result, according to our analysis, hospitals are expected to dominate the market for spinal fusion devices by the end-user.

The Market for Spinal Fusion Devices in Different Regions:

Our analysis divides the world into five regions: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The growing geriatric population in North America and the increased incidence of sports injuries and fatal accidents are among the primary drivers driving demand for spinal fusion devices in the North American region. Furthermore, the region’s well-developed healthcare infrastructure will likely drive market expansion for spinal fusion devices. Furthermore, essential player advancements are projected to enhance market growth by creating substantial untapped opportunities.

Insights for Key Players:

Alphatec Holdings, Inc., B. Braun Group, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, ORTHOFIX MEDICAL INC, Stryker, and Zimmer Biomet Holdings are some of the leading companies in the spinal fusion device market. With numerous large and small industry participants, the market for spinal fusion devices is very competitive. To get a more extensive market share, these companies pursue strategies such as geographical expansion, new product releases, partnerships, and collaborations.

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/global-spinal-fusion-market-procedure-volume-and-forecast-495-p.php

COVID-19’s Impact on the Global Spinal Fusion Device Market:

The COVID-19 epidemic has had an impact on just about every business. The market for spinal fusion devices, like other healthcare industries, has been completely impacted. The COVID-19 epidemic situation in several nations has created obstacles for spinal fusion devices used in hospitals and clinics to provide orthopedic services. One of the problems preventing clinics and hospitals from providing spine fusion services is the enormous strain on hospitals to offer COVID-19 patients.

Market Summary:

  • Product Type: We have covered Cervical Device, Thoracolumbar Device, Interbody Device an Biologics as product type.
  • Surgery Type: In our report we have studied, Open Surgery, Minimally Invasive
  • Disease Indicator Type: We have studied, Degenerative Disc Disease, Complex Deformity, Traumas & Fractures and Other
  • End-Users: Hospitals, Specialty Clinics and Ambulatory Surgical are the end-users covered in our report
  • Regions: In our report we have covered, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa
  • Company Analysis: The key players covered are Alphatec Holdings, Inc., B. Braun Group, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, Orthofix Medical Inc, Stryker, Zimmer Biomet Holdings)

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Ready to Drink Tea and Coffee Market is expected to reach US$ 153.19 Billion by 2027

According to Renub Research, report titled “Ready to Drink Tea and Coffee Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis” the Ready to Drink Tea and Coffee Market is expected to reach US$ 153.19 Billion by 2027. Globally, tea and coffee that are ready to drink are packaged beverages sold in a ready-to-drink state. To replace nutritional shortages, RTD tea and coffee can also be modified to deliver personalized health benefits to consumers, especially for children and women. As a result, young people in both developed and developing countries are switching to RTD beverages for a quick boost of energy instead of synthetic sports drinks. Furthermore, ready-to-drink tea and coffee can be used as a substitute for carbonated drinks. Remarkably, Ready to Drink Tea is regarded as a healthy beverage. At the same time, Ready to Drink Coffee is considered a reliable source of immediate energy.

Global Ready to Drink Tea and Coffee Market to Grow with a CAGR of 7.3% from 2022-2027

Worldwide Ready-to-Drink Tea and Coffee Market was valued at US$ 100.10 Billion

In recent years, due to customers’ busy and fast-paced lifestyles, ready-to-drink tea and coffee has seen increased demand as an alternative to carbonated drinks. In addition, changing lifestyles that encourage on-the-go eating and a growing tendency of substituting less nutritious snacks for meals has increased by global Ready to Drink Tea and Coffee acceptance. As a result, the market has been developing moderately with considerable growth rates over the last few years. It is anticipated to increase significantly in the anticipated period, i.e., 2021-2027.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=ready-to-drink-tea-and-coffee-market-p.php

How COVID-19 Benefited the Ready-to-Drink tea and Coffee Industry

The global ready-to-drink tea and coffee market rose due to the COVID-19. Restaurants, cafés, tea micro-roasters, and other out-of-home outlets have all been harmed by measures such as social separation and lockdowns. Nonetheless, the present trend toward online purchase for consumption at home is forcing retailers, roasters, and consumers to adjust to this new reality. As a result, this factor boosts the global consumption of RTD coffee and tea. As a result, demand for RTD tea and coffee increased in 2020, resulting in increased RTD tea and coffee retail sales.

Ready To Drink Tea Segment Holds a Significant Share of The Global Tea And Coffee Market:

Our report divides the market into two product categories: ready-to-drink tea and ready-to-drink coffee. The fastest-growing segment was Ready to Drink tea owing to the availability of the most appropriate tea tastes, such as fruit, black, green, herbal, matcha, oolong, and iced, as well as additional nutritional benefits such as necessary vitamins and minerals and a high supply of antioxidants. For example, catechin is present in RTD green tea. On the other hand, RTD coffee comes in a variety of flavors, including yerba mate, guarana, acai berry, ginseng, taurine, and iced varieties. In contrast, black coffee is high in vitamin B, potassium, magnesium, polyphenols, and caffeine.

The PET Bottle Segment is expected to have the largest market share:

The RTD tea and coffee industry is divided into four categories based on packaging: glass bottle, PET bottle, canned, and others. The PET bottle category is expected to have the most significant share in the worldwide RTD tea and coffee market. Notwithstanding, PET receptacles are in high demand among liquid manufacturers in the beverage packaging business because they are recyclable.

Distribution Channels in Ready-To-Drink Coffee and Tea Industry:

As per our analysis, ready-to-drink coffee and tea distribution are controlled by distribution channels such as supermarkets/hypermarkets, specialty stores, online stores, and others. Due to the significant increase in demand, Supermarkets/Hypermarkets and Specialty Stores are increasingly selling high-quality coffee and tea at cheap costs, appealing to busy consumers and effectively reacting to their lifestyles.

North America Has the Fastest-Growing Market for Ready-To-Drink Tea and Coffee:

As per our report estimates, due to increased consumer knowledge about the negative consequences of carbonated beverages, North America is the fastest-growing ready-to-drink tea coffee industry. Furthermore, due to increased demand for these products, Canada and the United States are driving the RTD tea and coffee business expansion in North American region. Moreover, the entire sector in the United States is expanding as the country’s health awareness grows.

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/ready-to-drink-tea-and-coffee-market-p.php

Key Market Players:

According to our report, Suntory Holdings Ltd, Nestle SA, Asahi Group Holdings Ltd, Uni-President Enterprises, PepsiCo Inc, The Coca-Cola Company, Starbucks Corporation, Monster Beverage Company, Danone, and Unilever are among the market’s key players. Furthermore, the analysis includes a global overview, recent developments/initiatives, and the revenue of the players mentioned above.

Market Summary:

  • Product Category: We have studied the market for RTD Tea, RTD Coffee as product categories in Ready to Drink Tea and Coffee Industry.
  • Packaging: Our report covers PET Bottle, Glass Bottle, Canned, Others as packaging used in Ready to Drink Tea and Coffee Market.
  • Distribution Channels: In our report we have studied Supermarket/Hypermarket, Specialty Stores, Online Store and Others as distribution channels of Ready to Drink Tea and Coffee Industry.
  • Region: We have studied the regional market of North America, Europe, Asia Pacific, Middle East & Africa, South America in Ready to Drink Tea and Coffee Market.
  • Company Analysis: Our report studies key players like Suntory Holdings Ltd, Nestle SA, Asahi Group Holdings Ltd, Uni-President Enterprises, PepsiCo Inc, The Coca-Cola Company, Starbucks Corporation, Monster Beverage Company, Danone, and Unilever.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Medical Adhesives Market Size is expected to expand at a CAGR of 7.9% during 2021-2027

According to Renub Research report titled “Medical Adhesives Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the Medical Adhesives Market to reach USD 15.30 Billion by 2027. In the assembly of medical devices, medical adhesives comprise an integral part of healthcare delivery and are used by almost every medical specialty in all care settings. Medical adhesives are biocompatible, and their features of not irritating, sensitizing, or cytotoxic have expanded their use in medical equipment. Medical adhesives are majorly utilized in the medical industry to close up a patch or dress the skin wounds, fix medical devices such as tape, etc. It is utilized for bone and enamel reconstruction during surgeries. Various products are involved in medical adhesives, such as dressing, electrodes, patches tapes, and ostomy supplies.

Worldwide Medical Adhesives Market Size was US$ 9.70 Billion in 2021

Nonetheless, the population in developed countries such as the U.S., Germany, and Japan is aging rapidly. As per the United States Census Board, people above 65 years would account for 20% of the total population by 2030. According to the (UNU) United Nations University, one million people reach 60 years of age every month globally. The increasing geriatric population is the factor that increases medical adhesives demand, which in turn anticipated driving the development of the global market in the next few years. Further, the demand for silicone-based medical adhesives is caused by their ability to adhesion silicon and other difficult-to adhere substrates. In addition, silicone is characterized by extreme weather resistance and has more extended durability than acrylics.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=medical-adhesives-market-p.php

Dental application is the Fastest-growing Segment of Medical Adhesives Industry

In terms of application, the global medical adhesives market is categorized into medical device & equipment, internal, external, dental, and others. Dental adhesives deliver retention to composite fillings or composite cement. These adhesives find use in pit & fissure sealants and dental repair applications. Products in dental applications include Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives.

Apart from this, medical devices & equipment are utilized for hearing-aid molding, polycarbonate component assembly (e.g., heat exchangers, blood oxygenators, and surgical pumps) anesthesia-mask bonding, needle assembly, bonding of other medical devices. The product’s substrate versatility, thermal solid & chemical resistance, low shrinkage, high gap filling, high peel, and rapid cure are the significant factors driving their growth in medical devices & equipment.

North America to Lead Global Medical Adhesives Industry

In North America, increased patient awareness levels regarding wound infections and diseases and the rapidly growing senior population in this region, especially in the U.S, are the significant factors contributing to market growth. The evolution of the market player’s focus towards developed wound dressings analogized to the traditional staple and suture methods is the major trend witnessed in this region.

Notwithstanding, the Asia Pacific is the fastest-growing medical adhesive market. The Asia-Pacific medical adhesive market is predicted to expand due to the growing population, driving up the need for better medical facilities and preferring adhesive medical demand. The consistent increase in government spending on the healthcare sector and the updating of healthcare infrastructure are market expansions in this area.

COVID-19 Impact on Medical Adhesive

The pandemic had ramifications for ways of working of various surgical procedures. There are stringent guidelines specific to each specialty that must be implemented and followed for surgeons to continue providing adequate care and safety to their patients during the COVID-19 pandemic. The volume of surgeries has significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries, impacting the procurement of the medical adhesives market.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/medical-adhesives-market-p.php

Key Market Players

Numerous big and small players characterize the global medical adhesives market. The major market players include Avery Dennison Corporation, Ashland Global Holdings Inc., H.B. Fuller Company, Henkel AG & Co. KGaA, The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Dupoint De Nemours, Inc and Wacker Chemie AG.

Market Summary:

Product – We have covered Market breakup by 2 viewpoints by product (Synthetic & Semi-Synthetic Adhesives (Acrylic, Polyurethane, Epoxy, Silicone, and Others) and Natural or Biological Adhesive (Fibrin, Collagen, Albumin, and Others)

Application – Our Report covers by Application in the 5 viewpoints (Dental (Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives), Internal (Bone, Cranial, Pulmonary and Abdominal), External (Tissue Bonding Agents and Prosthesis Bonding Agents), Medical Device & Equipment and Others)

Technology – Global Medical Adhesives Market have been covered by technology from 5 viewpoints (Water based, Solvent based, Hot melt, Reactive & Others)

Region – This Report covers Global Medical Adhesives Market breakup by 4 Region (North America, Europe, Asia – Pacific, Central & South America, and Middle East)

All the key players have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) H.B. Fuller Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Ashland Global Holdings Inc., The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Wacker Chemie AG, and Dupoint De Nemours, Inc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

United States Endoscopy Devices Market is expected to grow at a CAGR of 7.19% from 2021 to 2027

According to the latest report by Renub Research, “United States Endoscopy Devices Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the United States Endoscopy Devices Market Size is projected to reach US$ 27.9 Billion by 2027. Endoscopy devices are thin and long tubes inserted inside the body via mouth or incision to examine the interior of the bladder, stomach, ears, nose, esophagus, colon, throat, heart, joints, urinary tract, and abdomen. These tubes have a light source attached and a camera, which help healthcare professionals to perform laparoscopic and biopsies and arthroscopy surgeries. They are available in various lengths and flexibilities depending on diagnostic organs.

United States Endoscopy Devices Market to Grow with a CAGR of 7.19% from 2021 to 2027

United States Endoscopy Devices Market Size was US$ 18.8 Billion in 2021

The change in the trend of adoption from traditional open surgeries to minimally invasive techniques by healthcare professionals and patients is one of the primary factors growing the endoscopy devices market in the United States. Other factors promoting growth include the rising prevalence of chronic conditions, the increasing geriatric population, and technological advancements in endoscopy devices.

Moreover, the increasing number of neurological disorders and the rising adoption of minimally invasive surgeries attributed to the United States endoscopic devices market growth. As per ONP hospitals statistics, the United States contributes to 32% of the number, i.e., around 4,800,000 laparoscopic procedures are performed every year. This implies that endoscopic procedures are performed widely in the country.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-states-endoscopy-devices-market-p.php

Endoscopy Visualization Components product dominates the United States Endoscopy Devices Market

Depending on the product, the global endoscopy devices market is divided into Operative Devices, Endoscopy Visualization Components, Endoscopy Visualization Systems, and Endoscopes. The endoscopy visualization components register a significant dominance in the United States endoscopy devices industry. This is attributable to benefits provided by high-definition visualization systems for treating and diagnosing complex health conditions such as cancer, urinary disorders, GI disorders, and lung disorders and increasing preference of healthcare professionals towards utilizing endoscopy visualization systems for better diagnosis and treatment.

In United States G.I. Tumors accounts for the Second Highest Cause of cancer-related Deaths

In the United States, endoscopy sub-products like robot-assisted endoscopes, capsule endoscopes, and rigid endoscopes are widely used in various medical specialties applications, such as gastroenterology, urology, gynecology, pulmonology ENT, and others. The increasing burden of G.I. disorders, coupled with the growing geriatric population, is propelling the demand for Gastroenterology Endoscopy. G.I. tumors are the second most extensive cause of cancer-related deaths in the United States. Thus, an upsurge in endoscopic procedures for the early diagnosis of G.I. cancers offers considerable revenue opportunities.

Bariatric Surgery Drives the Capsule Endoscopy Market Growth

Although, sub-product Capsule endoscopy is widely used to detect minor bowel damage, Crohn’s disease, obscure intestinal bleeding, etc., in the United States. Capsule endoscopy has significant benefits for patients with small bowel disease for whom the proper diagnosis is not available. In addition, the capsule endoscope is on-demand due to its cost-effectiveness. Moreover, many surgical procedures using endoscopic procedures such as bariatric surgery boost the Capsule endoscopy market growth in the United States.

Besides, the market comprises both hospitals and ambulatory surgery centers/clinics by end-users. Nevertheless, in the United States, hospitals have emerged as the most primary health system. Thus, the number of endoscopic surgeries done at hospitals is relatively more than the other health systems, such as specialty clinics or Ambulatory Surgical Centers (ASCs).

COVID- 19 Impact on the United States Endoscopy Devices Industry:

COVID-19 is an incomparable global public health emergency that has affected the United States in almost every industry, including the endoscopy device industry. The primary cause for the decline in endoscopy procedures during the COVID-19 pandemic was decreased patient volume in hospitals due to delaying guidelines for safety reasons and rescheduling. Moreover, these delays happened after careful review of patient history, and healthcare providers rescheduled endoscopic procedures to minimize the chance of exposure to COVID-19 during hospital visits.

Competitive Landscape:

The United States endoscopy devices industry is highly competitive, and prominent players have adopted various strategies to increase their endoscopy devices market share. These include product launch, product development, product approval, and acquisition. Major US endoscopy devices market players include Boston Scientific Corporation, Medtronic Plc, Johnson and Johnson, Stryker, and Conmed.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-endoscopy-devices-market-p.php

Market Summary:

  • Product – We have covered United States Endoscopy Device Market breakup by 4 viewpoints by-product (Operative Devices, Endoscopy Visualization Components, Endoscopy Visualization Systems and Endoscopes)
  • Sub-Product – Renub Research Report covers by Sub-Product in the 5 viewpoints (Rigid Endoscopes, Robot Assisted Endoscopes, Disposable Endoscopes, Capsule Endoscopes and Flexible Endoscopes)
  • Application – Our Report has covered United States Endoscopy Device Market breakup by 6 Application (Gastroenterology, ENT Surgery, Gynecology, Neurology, Urology and Other Applications)
  • End Users – This Report covers by End Users in the 3 viewpoints (Hospitals, Ambulatory Surgery Centers/Clinics and Other End Uses)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Boston Scientific Corporation, Medtronic Plc, Johnson and Johnson, Stryker and Conmed.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

European Ice Cream Market is expected to grow with a CAGR of 4.59% during 2021-2027

According to Renub Research report titled “Europe Ice Cream Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Europe Ice Cream Market Size was US$ 21.7 Billion by 2021.  Ice-creams and frozen desserts are frozen foods traditionally eaten as snacks and desserts worldwide. Ice-creams are usually prepared from dairy products, say cream and milk. Flavors, colors, sweeteners, stabilizers, preservatives, and emulsifiers are added to enhance these products’ taste and shelf-life. Around the world, diverse cultures have different varieties of ice creams and frozen desserts popular in their countries. For instance, Italian people want Gelato after dinner or lunch.

Europe Ice Cream Market to reach US$ 28.4 Billion by 2027

Factors Driving the Europe Ice Cream Industry

In the European region, demands for ice-creams that are made using natural ingredients, low on fats, and at the same time don’t compromise on taste and indulgence is surging. European countries like Germany and Italy, UK are the biggest ice-cream markets. Over the time, indulgence and the growing consumer preference for ice cream as a leisure product drove the market’s growth, and new innovative flavors, offered by companies, further act as a catalyst for demand generation.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=europe-ice-cream-market-p.php

Besides, consumer demand for naturally flavored, rising health concerns, and sweetened ice-creams and handcrafted ice-creams is growing. Apart from that, product innovation in ice cream, economic growth, retail market expansion and growth in disposable income are projected to have high impact on ice cream market and market share in the European region.

European Ice Cream Market is expected to grow with a CAGR of 4.59% during 2021-2027

The development of retail channels contributes to the growth of the ice cream market. Further, retail channels such as hypermarkets, supermarkets, convenience stores, and others act as marketing tools that assist in building an impressive premium image and increase brand exposure of a wide variety of ice cream products. The company’s product innovation is also diversifying the offerings and assists in meeting varying consumer demands. While economic growth is also helping to continue to increase customers’ spending power. Also, increasing demand for innovative products and the development of lactose-free ice cream provides growth opportunities for the ice cream market extension. However factors like health concerns associated with ice creams may hinder the growth a bit.

COVID Impact on Europe Ice Cream Industry

During the COVID-19 pandemic, the European ice-cream market exhibited sluggish growth due to the economic slowdown and supply chain disruptions over the period. Further, market revenues continue to be impacted by growing health issues concerning lifestyle diseases and the pandemic. Also, European people were avoiding ice cream as they felt it made them susceptible to COVID-19. Moreover, we expect post-pandemic recovery and growth in the ice cream industry in the region.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/europe-ice-cream-market-p.php

Market Summary:

  • Product Type: The market has segmented into Artisanal, Impulse and Takes home
  • Ingredients: The report covers by Ingredients like Whole Milk, Skim Milk, Cream, Sweetening & Flavoring Agent, Other (Egg Yolk, Stabilizers, and Emulsifiers)
  • Category: We have studied the market by Category into Choc Snacks, Premium Ice-Cream, Luxury Ice Cream, Filled Cones, Children’s, Standard Ice-Cream, Adult Refresh, and Daily Ice Cream Desserts, and Individual Ice-Cream
  • Application: This segment is divided into Commercial and Residential
  • Distribution Channels:  Market is categorized into On Tread, Hypermarket & Supermarket, Food & Drink Specialists, Convenience Stores and Others
  • Producing country:  The markets of producing countries in the Europe are Germany, Italy, Spain, France and the United Kingdom
  • Company:  We have studied the Overviews, recent developments and sales analysis of following companies General Mills Inc., Nestle S.A., Unilever, Baskin Robbins, and Lotus Bakeries

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Worldwide Defibrillators Industry will grow at a CAGR of 5.76% during 2021-2027

The latest report by Renub Researh, titled “Defibrillators Market Size, Share, Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis”  the Global Defibrillators Market Size was valued at US$ 12.87 Billion in 2021. The World Health Organization states that cardiovascular deaths are the most common cause of all registered deaths worldwide. In addition, economic development rates and industrialization have significantly added to the number of deaths due to sudden cardiac arrest. Further, sudden cardiac arrests are accompanied by immediate resuscitation, a combination of chest compressions, and assisted ventilation. Hence, defibrillation is an effective treatment option accepted globally to treat cardiac arrest due to ventricular fibrillation. A defibrillator incorporates the concept of defibrillation, which is an electronic device, which is prominently used to treat arrhythmia and sudden cardiac arrest.

Global Defibrillators Market will be US$ 18.01 Billion by 2027

Worldwide Defibrillators Industry will grow at a CAGR of 5.76% during 2021-2027

SCA is a sudden and unanticipated pulseless situation caused by the cessation of cardiac mechanical activity. SCA is a foremost cause of death among adults, usually above the age of 40. SCA is one of the prominent driving factors for evolving the defibrillators industry. Moreover, the rising incidence of atherosclerosis, diabetes, strokes, hypertension, and others due to lifestyle habits such as unhealthy dietary habits, lack of physical activity, and smoking, among others, is the ultimate cause of CHF. Moreover, the rising geriatric population base is anticipated to fuel CHF prevalence, increasing defibrillator market growth.

External Defibrillator Is Expected to Grow at A Great Pace During The Forecast Period:

By Product type, we have categorized the global defibrillator market into the Implantable Cardioverter Defibrillator and External Defibrillator market. The demand for External Defibrillator will grow significantly during the forecast period. External defibrillators are life-saving devices that deliver a defibrillating shock to diagnose and restore heart rhythms in an unexpected cardiac arrest. Apart from that, the market of Implantable Cardioverter Defibrillator will also flourish during 2021-2027.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php

AED Is the Most Preferred External Defibrillation System:

External defibrillators are life-saving medical devices used to deliver defibrillating shock through paddles or electrode pads to diagnose and restore life-threatening abnormal heart rhythms in the conditions of unexpected cardiac arrest. These devices can perform cardioversion, defibrillation, and pacing of the heart. External defibrillators are of three major types: manual external defibrillators, AEDs and WCDs. AEDs are used in most cases among SCA patients due to abundant opportunities observed and ease in use, thereby bagging a significant market share in the global defibrillators market.

The North American Region Hold Considerable Share:

We have studied the regional realms of the global defibrillators industry in North America, Latin America, Europe, Asia Pacific and the Middle East and Africa region. Higher Adoption of Defibrillator Installations and Implants Enables Market to Hold Considerable Share in North America. North America is envisioned to dominate the market throughout the forecast period. Growing installations of external defibrillators in hospitals and public places such as schools, hotels, streets, railway stations, and others to prevent fatalities from sudden cardiac arrest are prominently responsible for holding a higher defibrillator market share in North America.

Moreover, the incremental shift of preference towards subcutaneous ICD due to growing patient awareness is projected to augment the growth of ICD in North America. Europe is anticipated to be the second most prominent region in terms of market share by 2027. In addition, the market is rising at a faster pace in emerging countries of the Asia Pacific region, owing to increasing adoption and rapidly developing healthcare infrastructure.

Key Market Players:

Medtronic, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, and Asahi Kasei Corporation are amongst a leading player in the defibrillator market owing to their diverse product offering in the implantable defibrillator segment, efficient customer reach, and vital after-sales service. Our report also covers operate in the defibrillator industry.

For instance, in April 2020 – Philips, a health technology company, announced that it’s Emergency Care and Resuscitation (ECR) business is recommencing the manufacturing and shipping of external defibrillators for the US. The company declared that the US Food and Drug Administration (FDA) had lifted the limitations imposed on the manufacturing and allocation of defibrillators in the US.

COVID-19 Impact on Global Defibrillators Market:

All over the world, COVID-19 is known to affect the cardiovascular system, resulting in myocardial injury, arrhythmias, intravascular thrombosis, and sudden cardiac death. Further, initial reports have also recommended a temporary association between COVID-19 activity and cardiac arrests in the community and in hospital settings. Remarkably, life-threatening arrhythmias have been variably reported among patients hospitalized for COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Hence, defibrillator shock episodes have risen during the higher COVID-19 activity boosting the market for Global Defibrillators Market.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/defibrillator-market-forecast-p.php

Market Summary:

  • Product Type: We have covered Implantable Cardioverter Defibrillator and External Defibrillator.
  • Implantable Cardioverter Defibrillator: We have studied Transvenous Implantable Cardioverter Defibrillators (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) and others in our report.
  • Transvenous Implantable Cardioverter Defibrillators: We have covered Single-Chamber Implantable Cardioverter Defibrillators, Dual-Chamber Implantable Cardioverter Defibrillators, Biventricular Implantable Cardioverter Defibrillators /Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
  • External Defibrillator: In our report we have studied Automated External Defibrillators, Advanced Life Support Defibrillators, Wearable Cardioverter Defibrillators
  • End Users: Hospital, Prehospital, Public Access Market, Alternate Care Market, Home Healthcare are the end users in the market.
  • Regions: We have studied the regional realms such as North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
  • Company: The key players studied in our report include Medtronic Plc, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, Asahi Kasei Corporation.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Biodegradable Plastic Industry will grow with a CAGR of 8.72% during 2020-2027

According to Renub Research report, tittled “Biodegradable Plastics Market Size, Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Biodegradable Plastics Market was USD 4.3 Billion in 2021. In the wake of plastic pollution increasing worldwide, biodegradable plastics are one of the fastest-growing segments within the global plastics industry. Nevertheless, Bioplastic is a sustainable material derived from renewable feedstocks, and is an alternative to petroleum-based plastics. It can reduce 30-70% of carbon dioxide emissions. It represents 42% reduction of carbon footprints. The production of bioplastic requires 65% less energy than conventional petroleum plastic.

Global Biodegradable Plastics Market to Reach USD 7.1 Billion by 2027


How Covid-19 Helped the Biodegradable Plastics Industry to Grow

The global biodegradable plastics industry witnessed a positive impact owing to the novel coronavirus lockdown globally. The number of medical items like sanitizer bottles, face masks, and gloves increased, creating huge plastic waste. This aspect has made a massive opportunity for biodegradable plastics to produce personal protective equipment and sanitizer bottles. Prominent industry leaders adopt different growth strategies like a geographical expansion to increase their capacity and productivity.


Global Biodegradable plastics Resin Market Drivers:

Worldwide, the increasing environmental concerns about plastic usage (as plastics contain toxic pollutants that harm animals, plants, and people) are propelling the use of biodegradable plastic alternatives. Floating plastic waste that survives thousands of years in water can perform as a transportation device for invasive species that disrupt habitats. This factor above is contributing to the growth of the market.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=biodegradable-plastic-market-p.php


Thus, the stringent regulations by various governments and federal agencies to reduce plastic waste and promote biodegradable plastics usage in packaging are expanding the demand of this market. The laws related to green packaging are rising. As a result, various FMCG companies are required to adopt biodegradable packaging to yield with the standards, which is propelling the blossoming of this market.


The use of Starch blends is stimulating the biodegradable plastics industry to blossom.

Based on material type, the biodegradable plastics market is divided into Polybutylene adipate Terephthalate (PBAT), Polybutylene Succinate (PBS), Polylactic Acid (PLA), Polyhydroxyalkanoate (PHA), and Starch Blends. Starch blends appeared as the global leader in revenue share in the biodegradable plastic market. This is accounted to its demand in flexible packaging and the agricultural sector. Starch blends are widely used to reduce the carbon footprint of conventional resins, thus enhancing demand growth.


Furthermore, the adoption of Polylactic Acid (PLA) bioplastic has increased tremendously across packaging and consumer goods applications due to the avant technical properties and functionalities. The demand for Polylactic Acid (PLA) bioplastics has gained tremendous traction in various plastic applications due to the favorable legislations implemented by many governments around the globe.


Moreover, there is an increased demand for bioplastic packaging for wrapping organic food and premium and branded products with specific needs. A combination of recycling components from conventional plastics, such as PET with bioplastics (bio-based PET), provides high-performance processing of bioplastics packaging. Biodegradable food packaging, certified as industrially compostable, was the first successfully commercialized bioplastic product.


North America is one the Biggest Consumer in Biodegradable Plastics

Regionally, the North American region is predicted to be one of the biggest consumers of biodegradable plastics, which is majorly credited to the extensive presence of packaged food manufacturers in Canada & the United States. Being environmentally conscious and increasing the spending power of the consumers is one of the significant drivers increasing the demand of the market in the region.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/biodegradable-plastic-market-p.php 


Further, the transition to a low-carbon and circular economy, more vital policy support for the economy, and raised consumer awareness for sustainable products and packaging are compelling the expansion of the market in Europe. The use of biodegradable plastics, primarily in European countries, also increases in other niche components, such as drug delivery systematical implants.


Key Players:

The global biodegradable plastic market is highly fragmented, as the international participants are driving toward inventing new technologies to manufacture pliable packaging material from different readily available natural resources. The players’ substantial investments in research and development to create innovative products generate high competition. The key players are Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (UK), and Green Dot Bioplastics.


Market Summary:

  • Material Type – Renub Research Report covers by Material Type in the 6 viewpoints (Polybutylene adipate Terephthalate (PBAT), Polybutylene Succinate (PBS), Polylactic Acid (PLA), Polyhydroxyalkanoate (PHA), Starch Blends and Others)
  • Applications – Our Report covers by Application in the 4 viewpoints (Packaging, Agriculture, Consumer Goods and Others)
  • Regions – This Report covers Market breakup by 5 Regions (North America, Europe, Asia-Pacific’s, Latin America and Middle East & Africa)
  • All the key  players have been shielded from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (UK) and Green Dot Bioplastics

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

China Automotive Vehicle Industry is expected to grow with a CAGR of 4.10% from 2021-2030

According to Renub Research report tittled “China Automobile Market, Size, Forecast 2021-2030, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” finds that the China Automobile Market was 27.71 Million Units in 2021. China is the largest automobile industry worldwide, both in demand and supply. The automobile sector is at a crossroads owing to changing customer behavior and direction. It is one of China’s most important economic sectors by revenue. China’s automobile industry has attracted many well-established foreign brands to invest in automobile production. Owning to technical development and lower production costs, various indigenous brands of China’s leading automobile manufacturers have gained popularity in the automobile market. The rapid growth of the Chinese domestic market has also further accelerated the automobile industry in China.

China Automobile Market to Reach 39.78 Million Units by 2027


Increasing Adoption of Electric and Hybrid Vehicles, due to Government Push

Based on category, the Chinese automotive vehicles industry’s principal categories include Electric Vehicle (EV), Hybrid Electric Vehicle (HEV), Plug-in Hybrid Electric Vehicle (PHEV), Mild Hybrid Electric Vehicle (MHEV), Natural Gas Vehicle (NGV), Fuel Cell Electric Vehicle (FCEV), Diesel Vehicle, and Petrol Vehicle. With accelerated urbanization and an increase in vehicle sales, China is planning to reduce exhaust emissions from vehicles. Meanwhile, the country also plans to reduce its dependence on oil imports, promoting electric vehicles.


In Addition, some major provinces and cities are imposing more stringent restrictions. For instance, Beijing only issues 10,000 licenses to register combustion-engine vehicles per month to encourage its citizens to switch to electric vehicles. Similarly, the Government of China had lifted taxes or given a substantial tax release on the purchase of EVs. These initiatives by the Chinese government had attracted a lot of customers to purchase EVs in this country. For instance, in 2020, the China government offered a 10% service tax waiver for electric vehicles to boost the demand in the automobile market.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=china-automobile-market-p.php 


Notwithstanding, there is a massive demand for the Plug-in Hybrid Electric Vehicles (PHEVs) due to their price compromise between large cars and small cars, and it is one of the several sought-after cars, after small SUVs. This is due to their compactness, price affordability, ease of use, and family friendliness. Besides, hybrid electric vehicles (HEVs) come with various benefits like reduced operational and maintenance costs and less pollution. With technological breakthroughs, the portfolio for electric vehicles is ever-expanding, with many consumers in China; different sectors preferring to go in for fully hybrid or mild hybrid vehicles due to their being less carbon-intensive.


COVID-19 Impact on China Automobile Industry

The COVID-19 pandemic had a swift and severe impact on the China automotive industry. Several Chinese vehicle parts plants had extended their seasonal shutdowns, and the automotive component supply chain has been disrupted, with some industrial areas in lockdown. Meanwhile, travel restrictions caused by COVID-19 have interrupted automobile material supplies that rely on imports, accelerating domestic substitute exploitation and inventory improvement for critical parts.


Additionally, massive lockdowns for controlling COVID-19 have disrupted productions and operations, which tends to expel small brands from the competitive market, concentrating China’s automobile industry on the leading brands. Finally, after the pandemic, the social distancing trend challenges automobile distribution channels with dealers, pushing automakers to develop innovative online selling channels.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/china-automobile-market-p.php


Key Players Performance

The leading Chinese automobile market is the Toyota Motor Corporation, Volkswagen, Daimler AG, Ford Motor Company, and Honda Motor Company. In 2020, Honda Motor Company, Ltd. announced its deals of all-new Honda Fit Hybrid vehicles. It is adorned with Honda’s 2-motor hybrid system, which makes the vehicle with an electric motor, which results in better fuel performance and smooth drive.


Market Summary:

  • Category – Renub Research Report covered by Product Category in the 8 viewpoints (Electric Vehicle (EV), Hybrid Electric Vehicle (HEV), Plug-in Hybrid Electric Vehicle (PHEV), Mild Hybrid Electric Vehicle (MHEV), Natural Gas Vehicle (NGV), Fuel Cell Electric Vehicle (FCEV), Diesel Vehicle, Petrol Vehicle)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Ford Motor Company, Volkswagen, Toyota Motor Corporation, Daimler AG, and Honda Motor Company.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch